Assessment of thiamine status in humans
Methods in Enzymology · 2026
DOI: 10.1016/bs.mie.2026.06.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2026. Verfasst von Kerry S Jones und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nutritional Biomarker Laboratory, Institute of Metabolic Science - Epidemiology, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Thiamine, Thiamine Deficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: National Institute for Health and Care Research, Rockefeller Foundation, NIHR Cambridge Biomedical Research Centre.
Abstract (Originalsprache)
Thiamine (vitamin B1) is an essential nutrient with established adverse health consequences associated with acute deficiency. Emerging evidence also suggests long-term neurocognitive deficits due to sub-clinical deficiency in early life, and there is a growing appreciation of a potential role for thiamine in Alzheimer's disease. Therefore, the assessment of thiamine biomarkers, particularly in large, population-based studies, is critical to grasp the true scope of this public health problem. The most reliable biomarkers of thiamine status are whole blood concentrations of thiamine diphosphate (ThDP) measured by high performance liquid chromatography (HPLC) with fluorescence detection or liquid chromatography tandem mass spectrometry (LC-MS/MS), and the functional assay of transketolase activity (erythrocyte transketolase activity coefficient, ETKAC). Plasma thiamine reflects recent intake, and is not a useful biomarker of thiamine status. This manuscript describes the different biomarkers and methods of assessment, their advantages and disadvantages, and related cutoffs for deficiency. A table of 'performance characteristics' is provided to guide users on the quality and performance characteristics of each assay, and practicalities related to their cost, resource requirement, and maintenance. Provision of these insights will help inform decisions about inclusion of thiamine analysis in future work to better understand the extent of global thiamine deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutritional Biomarker Laboratory, Institute of Metabolic Science - Epidemiology, University of Cambridge, Cambridge, United Kingdom.
- Laboratory of Neurophysiology, GIGA Institute, University of Liège, Liège, Belgium.
- Department of Pathology, University of Utah Health, Salt Lake City, UT, United States.
- Department of Applied Human Nutrition, Mount Saint Vincent University, Halifax, Nova Scotia, Canada. Electronic address: Kyly.Whitfield@msvu.ca.
Förderung
- National Institute for Health and Care Research
- Rockefeller Foundation
- NIHR Cambridge Biomedical Research Centre
Zitieren
APA
Jones, K. S., Bettendorff, L., Frank, E. L., & Whitfield, K. C. (2026). Assessment of thiamine status in humans. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2026.06.018
Vancouver
Jones KS, Bettendorff L, Frank EL, Whitfield KC. Assessment of thiamine status in humans. Methods in Enzymology. 2026. doi:10.1016/bs.mie.2026.06.018
BibTeX
@article{Jones2026,
author = {Jones, Kerry S and Bettendorff, Lucien and Frank, Elizabeth L and Whitfield, Kyly C},
title = {Assessment of thiamine status in humans},
journal = {Methods in Enzymology},
year = {2026},
doi = {10.1016/bs.mie.2026.06.018}
}
EUVIMED